Universe Pharmaceuticals INC (NASDAQ: UPC) is 8.96% higher on its value in year-to-date trading and has touched a low of $0.75 and a high of $5.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The UPC stock was last observed hovering at around $1.93 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $2.19, the stock is 22.80% and 20.27% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.15 million and changing 13.47% at the moment leaves the stock 29.32% off its SMA200. UPC registered -37.25% loss for a year compared to 6-month gain of 119.00%. The firm has a 50-day simple moving average (SMA 50) of -$0.16 and a 200-day simple moving average (SMA200) of $1.58.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 36.87% loss in the last 1 month and extending the period to 3 months gives it a 18.38%, and is 5.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.07% over the week and 12.65% over the month.
Universe Pharmaceuticals INC (UPC) has around 225 employees, a market worth around $7.99M and $32.31M in sales. Profit margin for the company is -19.08%. Distance from 52-week low is 192.00% and -62.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.59%).
2 institutions hold shares in Universe Pharmaceuticals INC (UPC), with institutional investors hold 0.51% of the company’s shares. The shares outstanding are 3.62M, and float is at 1.57M with Short Float at 0.01%. Institutions hold 0.22% of the Float.
The top institutional shareholder in the company is Acadian Asset Management. LLC with over 6555.0 shares valued at $14158.0. The investor’s holdings represent 0.03% of the UPC Shares outstanding. As of Jun 29, 2023, the second largest holder is Renaissance Technologies, LLC with 4003.0 shares valued at $8646.0 to account for 0.02% of the shares outstanding. The other top investors are HRT Financial LP which holds 2783.0 shares representing 0.01% and valued at over $6011.0, while Two Sigma Securities, LLC holds 0.01% of the shares totaling 3081.0 with a market value of $6654.0.
